Name
CTCb
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CTCb
Name
Alternate Names
Oncotepa
Oncotiotepa
Tepa
Tespa
Tespa-min
Tespamine
Thio
Thio-tepa
Thiofozil
Thiophosphamide
Thioplex
Thiotef
Tifosyl
Tio-TEF
Tiofosfamid
Tiofosyl (Sweden)
Tiofozil
Triethylene thiophosphoramide
WR-45312
Abbreviations
STEPA
TESP
TESPA
Thio-TEPA
TSP
TSPA
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
006396
6396
Primary Site
None
Histology
None
Remarks
Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.
Coding
This drug should be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
Name
Alternate Names
JM 8
JM-8
JM8
Paraplatin
Abbreviations
CBDCA
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
241240
Primary Site
All cancers
Histology
None
Remarks
A platinum-salt alkylating agent.
Coding
This drug should be coded